Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/18/2013 | EP2673004A1 Hydrophobic modified peptides and their use for liver specific targeting |
12/18/2013 | EP2673001A2 Nts-polyplex nanoparticles system for gene therapy of cancer |
12/18/2013 | EP2673000A2 Polymer-carbohydrate-lipid conjugates |
12/18/2013 | EP2672999A2 Improved immunotherapy |
12/18/2013 | EP2672998A1 Injectable thermoresponsive polyelectrolytes |
12/18/2013 | EP2672993A1 Adjuvant compositions with 4-ibbl |
12/18/2013 | EP2672986A2 Lyophilized formulations |
12/18/2013 | EP2672982A2 Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof |
12/18/2013 | EP2672962A1 Novel antifungal composition |
12/18/2013 | EP2672958A1 Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia |
12/18/2013 | EP2672956A1 Novel formulations for dermal, transdermal and mucosal use 1 |
12/18/2013 | EP2672953A1 Artificial oil bodies |
12/18/2013 | EP2314327B1 Injectable cross-linked polymeric preparations and uses thereof |
12/18/2013 | EP2274018B1 Modified hydroxypolymer conjugates with bone-seeking and tumor-killing moieties |
12/18/2013 | EP2246362B1 Polymer conjugates of mutated neublastin |
12/18/2013 | EP2092069B2 Modified soluble fgf receptor fc fusions with improved biological activity |
12/18/2013 | EP1656952B1 Polyalkylene glycol conjugates of interferon beta-1A and uses thereof |
12/18/2013 | EP1613272B1 Method for preparation of site-specific protein conjugates |
12/18/2013 | EP1452174B1 Stabilized composition comprising reduced coenzyme q10 |
12/18/2013 | EP1283704B1 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents |
12/18/2013 | CN203342063U Contraceptive patch |
12/18/2013 | CN103460052A Paper support and method of recovering biological material therefrom |
12/18/2013 | CN103459430A Process for producing cellulose derivatives of high bulk density and good flowability |
12/18/2013 | CN103459362A A complex of garcinol, cyclodextrin and method thereof |
12/18/2013 | CN103458931A Nts-polyplex nanoparticles system for gene therapy of cancer |
12/18/2013 | CN103458930A Human antibodies and antibody-drug conjugates against CD74 |
12/18/2013 | CN103458929A Fat emulsion containing prostaglandin |
12/18/2013 | CN103458928A (R)-1,2-propanediol for use as solvent in therapeutic cooling agent compositions |
12/18/2013 | CN103458924A Adjuvant compositions with 4-lBBL |
12/18/2013 | CN103458879A Osmotic mediated release synthetic nanocarriers |
12/18/2013 | CN103458873A Fatty acid acylated amino acids for oral peptide delivery |
12/18/2013 | CN103458869A Externally used drug kit |
12/18/2013 | CN103458866A 囊泡组合物 Vesicle composition |
12/18/2013 | CN103458865A Composition for external application |
12/18/2013 | CN103458864A Liquid composition for oral cavity and method for stable addition of components to composition |
12/18/2013 | CN103458855A Manufacturing method for O/W emulsion composition |
12/18/2013 | CN103450483A Random copolymer based on polyphosphoester as well as preparation method and application thereof |
12/18/2013 | CN103450468A PEGylated artesunate derivatives, and pharmaceutical compositions and uses thereof |
12/18/2013 | CN103450371A Tetrahydro-beta-carbolinyl-3-formacyl-diethylenetriamino-beta-cyclodextrins, and preparation, antithrombotic activity and application thereof |
12/18/2013 | CN103450364A High-substitution-degree carboxymethyl starch and composite hydrogel thereof, and preparation method and application of carboxymethyl starch and composite hydrogel thereof |
12/18/2013 | CN103450361A Carboxymethyl cellulose grafted polylactic acid amphiphilic polymer, as well as preparation method and application thereof |
12/18/2013 | CN103449406A Powdery carbon aerogel, as well as preparation method and application thereof |
12/18/2013 | CN103446590A Immunoadsorbent for treating dilated cardiomyopathy and preparation method thereof |
12/18/2013 | CN103446589A Tetrahydro-beta-carbolinyl-3- formyl-diethylenetriamino-beta-cyclodextrin copper complex, and preparation, antithrombotic action and application thereof |
12/18/2013 | CN103446588A Targeted diagnosis and treatment combined medicine and preparation method and applications thereof |
12/18/2013 | CN103446492A Selenium butyric acid inclusion agent and preparation method thereof |
12/18/2013 | CN103446435A Polygonatum odoratum buccal tablet and production method thereof |
12/18/2013 | CN103446411A Softgel containing bezoar, snake gall and tendril-leaved fritillary bulb |
12/18/2013 | CN103446237A Rectal gelata of traditional Chinese medicine composition and preparation method thereof |
12/18/2013 | CN103446236A Dispersible tablet of traditional Chinese medicine composition |
12/18/2013 | CN103446187A Anti-inflammation and detumescent pharmaceutical composition and preparation method and applications thereof |
12/18/2013 | CN103446180A Bacterial cellulose-chitosan plural gel as well as preparation method thereof and application thereof in intracorporal treatment |
12/18/2013 | CN103446157A Compound amino acid-vitamin capsule and preparation method thereof |
12/18/2013 | CN103446077A Salbutamol sulfate oral instant membrane and preparation method thereof |
12/18/2013 | CN103446075A Cefaclor capsule and preparation method thereof |
12/18/2013 | CN103446074A Clarithromycin capsule and preparation method thereof |
12/18/2013 | CN103446071A Oral tablet and preparation method and application thereof |
12/18/2013 | CN103446070A Roflumilast solid quick-release preparation and preparation method thereof |
12/18/2013 | CN103446068A Bortezomib freeze-dried composition and preparation method thereof |
12/18/2013 | CN103446067A Oxiracetam freeze-drying preparation for injection and preparation method thereof |
12/18/2013 | CN103446066A Paroxetine liensinine freeze-dried powder and preparation method thereof |
12/18/2013 | CN103446065A Esomeprazole sodium freeze-dried powder injection for injection and preparation method thereof |
12/18/2013 | CN103446064A Chlorogenic acid powder-injection and preparation method thereof |
12/18/2013 | CN103446060A Docetaxel polydroxybutyrate nanoparticle, manufacturing method and pisum sativum agglutinin modification method and application |
12/18/2013 | CN103446057A Oral curcumin nano-granule and preparation method thereof |
12/18/2013 | CN103446055A Preparation method for genistein lipid nano body |
12/18/2013 | CN103446054A Liposome combination drugs, industrial production process of liposome combination drug through molecular dispersion method, and quality control |
12/18/2013 | CN103446053A Targeting liposome drug delivery system for multidrug resistant tumors |
12/18/2013 | CN103446049A 克拉霉素注射液及其制备方法 Clarithromycin injection and preparation method |
12/18/2013 | CN103446048A Famotidine injection and preparation method thereof |
12/18/2013 | CN103446047A Cefotiam hydrochloride pharmaceutical composition for injection and preparation method thereof |
12/18/2013 | CN103446045A Stable busulfan injection |
12/18/2013 | CN103446043A In-situ gel injection implant |
12/18/2013 | CN103446040A Docetaxel-coated polymeric micelle and preparation method thereof |
12/18/2013 | CN103191185B Antipyretic gel |
12/18/2013 | CN102871970B Puerarin oral adhesion microballoon spheres and preparation method thereof |
12/18/2013 | CN102871953B Super-absorbent adsorption suppository |
12/18/2013 | CN102772396B Cooperatively used combination type preparation for cleaning and sterilizing skin after being bitten or scratched by animals |
12/18/2013 | CN102764424B Drug composition of thymopentin composed of five kinds of amino acids and preparation method thereof |
12/18/2013 | CN102755285B Hormone cream |
12/18/2013 | CN102746380B Application of angiogenesis inhibitor polypeptide to preparation of medicine for treating tumor and rheumatoid arthritis |
12/18/2013 | CN102731777B Synthesis method of poly-benzyl L-glutamate/ethyl polyphosphate block copolymer |
12/18/2013 | CN102727906B Clathrates of N-methyl-4-(4-(3-trifluoromethyl)benzoylamino)phenoxyl)nicotinamide and salt thereof, preparation method thereof, and application thereof |
12/18/2013 | CN102716491B Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same |
12/18/2013 | CN102716103B 2, 2', 6, 6'-tetraisopropyl-4, 4'-2-biphenol soft capsule and method for preparing same |
12/18/2013 | CN102600250B In-situ gel sustained-release preparation of Ranunculus ternatus Thunb., and its preparation method |
12/18/2013 | CN102580232B Silk fibroin micro-needle system, silk fibroin nanometer particle and preparation method thereof |
12/18/2013 | CN102525959B Fat-soluble vitamin composition for injection and preparation method thereof |
12/18/2013 | CN102492182B Biofilms of rare-earth element contained chitosan and/or derivatives of chitosan |
12/18/2013 | CN102397593B Embolization particles developable under X-rays and preparation method and application thereof |
12/18/2013 | CN102397385B Injection prepared from heartleaf houttuynia herb and preparation method thereof |
12/18/2013 | CN102335435B Multifunctional polyurethane medicament carrier as well as preparation method and application thereof |
12/18/2013 | CN102264398B Synthesis of polymer conjugates of indolocarbazole compounds |
12/18/2013 | CN102100668B Advanced fatty acid derivative micro emulsion and preparation method and application thereof |
12/18/2013 | CN101897721B Colon cleansing compositions |
12/18/2013 | CN101842082B Peptide slow-release formulations |
12/18/2013 | CN101704870B Glutaryl cholesterol and liposome thereof and application of liposome as vaccine adjuvant |
12/18/2013 | CN101524336B Dosage forms for oral administration of magnesium salt of pantoprazole |
12/18/2013 | CN101370453B Compositions and methods for dermal delivery of drugs |
12/18/2013 | CA2819154A1 Methods and pharmaceutical compositions for treatment of central nervous system disorders with therapeutic agent(s) in patients with concurrent non-cns condition(s) or disorders contraindicating systemic administration of the therapeutic agent(s) |